Sulfonamides as a subject to study molecular interactions in crystals and solutions: Sublimation, solubility, solvation, distribution and crystal structure

International Journal of Pharmaceutics

Volumn 349, Issue 1-2, 2008, Pages 300-313

  Perlovich, German L ^a,c   Strakhova, Nadezda N ^a   Kazachenko, Vladimir P ^a   Volkova, Tatyana V ^c   Tkachev, Valery V ^a,b   Schaper, Klaus Jurgen ^d   Raevsky, Oleg A ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b INSTITUTE OF PROBLEMS OF CHEMICAL PHYSICS   (Russian Federation)

^c INSTITUTE OF SOLUTION CHEMISTRY   (Russian Federation)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

4 Amino N (2,3 dichlorophenyl) benzene sulfonamide; 4 Amino N (2,5 dichlorophenyl) benzene sulfonamide; 4 Amino N (3,4 dichlorophenyl) benzene sulfonamide; 4 Amino N (4 chlorophenyl) benzene sulfonamide; Crystal structure; Solubility; Solvation; Sublimation thermodynamics; Transfer process

Indexed keywords

4 AMINO N (2,3 DICHLOROPHENYL) BENZENE SULFONAMIDE; 4 AMINO N (2,5 DICHLOROPHENYL) BENZENE SULFONAMIDE; 4 AMINO N (3,4 DICHLOROPHENYL) BENZENE SULFONAMIDE; 4 AMINO N (4 CHLOROPHENYL) BENZENE SULFONAMIDE; OCTANOL; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG DISTRIBUTION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STRUCTURE; EVAPORATION; HYDROGEN BOND; MOLECULAR INTERACTION; PRIORITY JOURNAL; SOLVATION; TEMPERATURE DEPENDENCE; THERMODYNAMICS; VAPOR PRESSURE; X RAY DIFFRACTION;

ALGORITHMS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PHARMACEUTICAL SOLUTIONS; SOLUBILITY; SOLVENTS; SULFONAMIDES; TEMPERATURE; THERMODYNAMICS; X-RAY DIFFRACTION;

EID: 37349085224     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.07.034     Document Type: Article

References (26)

1. Adsmond D.A., and Grant D.J.W. Hydrogen bonding in sulfonamides. J. Pharm. Sci. 90 (2001) 2058-2077
2. Anderson G.W., Faith H.E., Marson H.W., Winnek P.S., and Roblin R.O. Studies in chemotherapy. 6. Sulfanilamido heterocycles. J. Am. Chem. Soc. 64 (1942) 2902-2905
3. Chickos J.S., and Acree Jr. W.E. Enthalpies of sublimation of organic and organometallic compounds, 1910-2001. J. Phys. Chem. Ref. Data 31 (2002) 537-698
4. Cox J.D., and Pilcher G. Thermochemistry of organic and organometallic compounds (1970), Academic Press, London
5. Crosley M.L., Northey E.H., and Hultquist M.E. Sulfanilamide derivatives. 5. Constitution and properties of 2-sulfanilamidopyridine. J. Am. Chem. Soc. 62 (1940) 372-374
6. Dannenfelser R.-M., and Yalkowsky S.H. Predicting the total entropy of melting: application to pharmaceuticals and environmentally relevant compounds. J. Pharm. Sci. 88 (1999) 722-724
7. Enraf-Nonius, 1989. CAD-4 Software. Version 5.0. Enraf-Nonius, Delft, The Netherlands.
8. Etter M.C. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc. Chem. Res. 23 (1990) 120-126
9. Guillory J.K. In: Brittain H.G. (Ed). Polymorphism in pharmaceutical solids (1999), Marcel Dekker Inc., New York 183-226
10. Gutsche K., Schröder E., Rufer C., and Loge O. Neue blutzuckersenkende Benzolsulfonamido-pyrimidine (New blood glucose lowering benzenesulfonamido-pyrimidines). Arzneim.-Forsch./Drug Res. 24 (1974) 1028-1039
11. Korolkovas A. Essentials of Medicinal Chemistry. second ed. (1988), Wiley, New York pp. 699-716
12. Mandell G.L., and Sande M.A. In: Gilman A., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman, The Pharmacological Basis of Therapeutics. eighth ed. 2 (1992), McGraw-Hill, Singapore 1047-1057
13. Pascual-Ahuir J.L., and Silla E. GEPOL: an improved description of molecular surfaces. I. Building the spherical surface set. J. Comp. Chem. 11 (1990) 1047
14. Perlovich G.L., and Bauer-Brandl A. Solvation of drugs as a key for understanding partitioning and passive transport exemplified by NSAIDs. Curr. Drug Deliv. 1 (2004) 213-226
15. Perlovich G.L., Kurkov S.V., and Bauer-Brandl A. The difference between partitioning and distribution from a thermodynamic point of view: NSAIDs as an example. Eur. J. Pharm. Sci. 27 (2006) 150-157
16. Perlovich G.L., Tkachev V.V., Schaper K.J., and Strakhova N.N. 4-Amino-N-(2,3-dichlorophenyl)benzenesulfonamide. Acta Crystallogr. E62 (2006) o5634-o5636
17. Perlovich G.L., Tkachev V.V., Schaper K., and Raevsky O.A. N-(2-Chlorophenyl)benzenesulfonamide. Acta Crystallogr. E62 (2006) o780-o782
18. Perlovich G.L., Tkachev V.V., Schaper K., and Raevsky O.A. Determination of the structure of N-(4-chlorophenyl)-benzenesulfonamide. Acta Crystallogr. E62 (2006) o376-o378
19. Perlovich G.L., Tkachev V.V., Kazachenko V.P., and Raevsky O.A. 4-Amino-N-(2,5-dichlorophenyl)benzenesulfonamide. Acta Crystallogr. E63 (2007) o1526-o1528
20. Perlovich G.L., Strakhova N.N., Kazachenko V.P., Volkova T.V., Tkachev V.V., Schaper K.J., and Raevsky O.A. Studying thermodynamic aspects of sublimation, solubility and solvation processes and crystal structure analysis of some Sulfonamides. Int. J. Pharm. 334 (2007) 115-124
21. Sheldrick G.M. SHELXL97 and SHELXS97 (1997), University of Göttingen, Germany
22. Tkachev V.V., Schaper K.J., Strakhova N.N., and Kazachenko V.P. N-(2,3-Dichlorophenyl)benzenesulfonamide. Acta Crystallogr. E62 (2006) o2514-o2515
23. Ucucu U., Isikdag I., and Dogu H. Acta Pharm. Turc. 37 (1995) 134
24. Verevkin S.P., and Schick C. Determination of vapor pressures, enthalpies of sublimation, and enthalpies of fusion of benzenetriols. Thermochim. Acta 415 (2004) 35-42
25. Zielenkiewicz W., Golankiewicz B., Perlovich G.L., and Kozbial M. Aqueous solubilities, infinite dilution activity coefficients and octanol-water partition coefficients of tricyclic analogues of acyclovir. J. Solut. Chem. 28 (1999) 737-751
26. Zielenkiewicz W., Perlovich G., and Wszelaka-Rylik M. The vapour pressure and the enthalpy of sublimation determination by inert gas flow method. J. Therm. Anal. Calorim. 57 (1999) 225-234